Atrial fibrillation density: biological signal or prognostic tool?

References

[1] Lip GYH,Boriani G.Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report.Chest2018;154:1121-201

[2] Chen LY, Chung MK, Allen LA, et al.; American Heart Association Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Quality of Care and Outcomes Research, and Stroke Council. Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American Heart Association.Circulation2018;137:e623-44

[3] Joglar JA, Chung MK, Armbruster AL, et al.; Peer Review Committee Members. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation2024;149:e1-e156

[4] Rosman L,Sarkar S,Passman RS.Atrial fibrillation density as a biomarker for ischaemic stroke risk prediction.Eur Heart J2026:ehag203

[5] Charitos EI,Ziegler PD.A comprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence: insights from 647 continuously monitored patients and implications for monitoring after therapeutic interventions.Circulation2012;126:806-14

[6] Kamel H,Longstreth WT Jr,Soliman EZ.Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation.Future Cardiol2015;11:323-31

[7] Bertelsen L,Haugan KJ.Left atrial late gadolinium enhancement is associated with incident atrial fibrillation as detected by continuous monitoring with implantable loop recorders.JACC Cardiovasc Imaging2020;13:1690-700

[8] Holmberg MJ.Collider bias.JAMA2022;327:1282-3

[9] Lawlor DA,Davey Smith G.Triangulation in aetiological epidemiology.Int J Epidemiol2016;45:1866-86